Skip to Content

BlackRock LifePath® Dyn 2040 Instl STLEX Fund Analysis

| Analyst rating as of | See BlackRock Investment Hub

Morningstar’s Analysis STLEX

Will STLEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Don't look any further.



The BlackRock LifePath Dynamic target-date series benefits from a veteran management team and a careful approach to taking thoughtful risks. It continues to earn a Morningstar Analyst Rating of Silver for its cheapest share classes. The more expensive shares earn Bronze or Neutral ratings.

Unlock our full analysis with Morningstar Investor